KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,274,000 | +947.9% | 28,966 | +498.2% | 0.08% | +1420.0% |
| Q4 2016 | $217,000 | -12.5% | 4,842 | +9.2% | 0.01% | +25.0% |
| Q3 2016 | $248,000 | -76.8% | 4,433 | -79.2% | 0.00% | -77.8% |
| Q2 2016 | $1,067,000 | +246.4% | 21,333 | +285.1% | 0.02% | +500.0% |
| Q3 2015 | $308,000 | +44.6% | 5,540 | +58.3% | 0.00% | +50.0% |
| Q2 2015 | $213,000 | -86.2% | 3,500 | -86.9% | 0.00% | -86.7% |
| Q1 2015 | $1,541,000 | – | 26,708 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |